Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
about
Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomasThe surgical management of paediatric bladder and prostate rhabdomyosarcomaRhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studiesSparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of Pediatric Oncology, Malignant Mesenchymal Tumors (SIOP-MMT) Working Group.Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's OncConcurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma.Prognostic significance of tumor response at the end of therapy in group III rhabdomyosarcoma: a report from the children's oncology group.Treatment results for patients with localized, completely resected (Group I) alveolar rhabdomyosarcoma on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III and IV, 1984-1997: a report from the Children's Oncology GroupTreatment modalities of bladder/prostate rhabdomyosarcoma: a review.Paediatric rhabdomyosarcoma of the ear and temporal bone.Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvementPrognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.AMORE protocol in pediatric head and neck rhabdomyosarcoma: descriptive analysis of failure patterns.Current chemotherapeutic strategies for rhabdomyosarcoma.Role of surgery in the management of soft tissue tumors.Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups.Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups.Selecting multimodal therapy for rhabdomyosarcoma.What is new in rhabdomyosarcoma management in children?Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome.Impact of extensive surgery in multidisciplinary approach of pterygopalatine/infratemporal fossa soft tissue sarcoma.Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies.Long-term evaluation of orbital rhabdomyosarcoma in children.Vulvar sarcomas: Short guideline for histopathological recognition and clinical management. Part 1.Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma.Effect of alpha lipoic acid on ifosfamide-induced central neurotoxicity in rats.Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal TumouThe prognostic value of early radiographic response in children and adolescents with embryonal rhabdomyosarcoma stage IV, metastases confined to the lungs: A report from the Cooperative Weichteilsarkom Studiengruppe (CWS).Long-term survival results of pediatric rhabdomyosarcoma patients: a single-center experience from Turkey.Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International SocietConservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
P2860
Q24234049-45C60810-279A-4F15-ADE3-2841122DCA64Q27015190-3096A510-03B1-4DB0-A0BF-A79C9AF52583Q33559468-5DE3B559-1B4F-4582-97D6-0A3F92B46F0CQ33873982-F229A9B2-EBD6-403F-9561-E579E056CD35Q34402527-A66EFA33-10A4-48BF-AEA7-0DE6090E19F0Q34464249-8E3637BD-A207-4B9D-A2EB-D36A1DBF671AQ34490071-C57A1302-867C-4F89-BC33-881E6F565849Q35084182-03347CF4-6B3E-49B7-8957-6C3C52DF359CQ35154422-909804FB-EF97-4A81-A267-D59132154996Q35666521-F1F1D7F1-54DA-41C2-B146-DC099AA6E89FQ35848291-465F1E7F-8571-4B54-BDB1-091A935A63ABQ36022696-2D446055-EB1F-4EB6-A732-D68B7E480A18Q36096011-3ED38862-7A75-423D-A605-D74977F26AE1Q36118405-21BF105C-EA76-4304-9026-2923DE70088AQ36616534-A0E484FA-8E95-44CD-BCB8-79CF4E2485F6Q37212341-8C4A9526-36CE-4B29-9B67-F686BCCD2550Q37404111-258869BA-A8C9-4E38-B950-7131AFDBB465Q37782096-337CD618-837E-4046-9204-408D4CB97143Q38050831-AB1F3B1B-4C4D-41DC-AECF-901875C67ECFQ38777057-FC1CE41B-44E1-4B06-994D-D0153DF08925Q39488682-7B09BDBD-9D8A-4C41-97A9-D55787159E83Q39559369-0E526B69-1ACF-417E-AC46-C752F21793CAQ44779744-945768E7-2ABB-4607-AF4B-A7A3739ABD32Q45011451-265EF645-CCC8-4F19-A889-F57F9BD5E44CQ45182250-B5DB0DF2-42B6-4536-9581-D02EF07908A8Q48005919-AFEFF62F-67AA-4B42-B8D4-4772D82366EBQ48695620-4D263B0C-265F-459C-841D-C3E669F02B90Q50862607-D86585C4-92CE-4740-81DA-8F09C592C257Q51362963-B3960898-5C09-4819-9EFF-E24B240C789DQ51697406-45F70EFE-CA86-4658-8085-C0BD65D68C63Q51787493-B69BD899-1425-4972-9AA9-A1A1F65BAE51
P2860
Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Treatment of non-metastatic rh ...... of Paediatric Oncology: MMT84.
@en
Treatment of non-metastatic rh ...... of Paediatric Oncology: MMT84.
@nl
type
label
Treatment of non-metastatic rh ...... of Paediatric Oncology: MMT84.
@en
Treatment of non-metastatic rh ...... of Paediatric Oncology: MMT84.
@nl
prefLabel
Treatment of non-metastatic rh ...... of Paediatric Oncology: MMT84.
@en
Treatment of non-metastatic rh ...... of Paediatric Oncology: MMT84.
@nl
P2093
P1476
Treatment of non-metastatic rh ...... of Paediatric Oncology: MMT84.
@en
P2093
Brunat-Mentigny M
Habrand JL
Martelli H
Praquin MT
Quintana E
P304
P356
10.1016/S0959-8049(98)00024-0
P577
1998-06-01T00:00:00Z